CSN Login
Members Online: 9

FDA meeting to discuss trial drug

JAWsSavannah
Posts: 57
Joined: Jun 2009

If there are any others on here in the clinical trial for pazopanib you might be interested to know there will be a FDA public advisory committee meeting (open to the public) on October 5, the purpose of which is to gather information the FDA needs to make a decision about approval of the experimental drug pazopanib. The manufacturer has applied for approval specifically for treatment of kidney cancers but, if approved for that, I would assume approval for thyroid cancer treatment will not be far behind. If approved, pazopanib will be marketed under the brand name Votrient. Details about the meeting time and location can be found here:

http://edocket.access.gpo.gov/2009/pdf/E9-20379.pdf

Contact names and phone numbers are also included.

That is a two page PDF document dealing with several matters. The Votrient-pazopanib stuff can be found on the second page, left hand column, item (2) on the agenda.

JAWsSavannah
Posts: 57
Joined: Jun 2009

We can view the meeting on Monday, October 5, via webcast. Go to this link for the details about signing up to view it:

http://www.z2systems.com/kca/viewtopic.php?p=13947#13947

Perstephanie
Posts: 28
Joined: Feb 2010

Did anything ever happen with this?

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network